Clinical TrialsSearch results
Number of results: 954
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- An Investigator-Initiated Phase II Clinical Trial of a Therapeutic Agent for Clozapine-Induced Sialorrhea
- Clozapine-induced sialorrhea
- Niitsu Tomihisa
- 2026-04-20
Not yet recruiting
- An exploratory clinical study on the relaxation effects of a single session of alpha-theta training in patients hospitalized in a palliative care unit.
- cancer
- Miura Tomofumi
- 2026-04-13
Recruiting
- A Phase IIb dose-ranging study to assess the efficacy and safety of GIA632 in participants with non-segmental vitiligo
- Non-segmental Vitiligo (NSV)
- Shimizu Kenichi
- 2026-04-07
Recruiting
- A study in people with advanced cancer to test how well different doses of BI 3819026 are tolerated when taken alone and together with ezabenlimab
- colorectal cancer, non-small cell lung cancer, breast cancer, melanoma, hepatocellular carcinoma and
- Takeuchi Yoshito
- 2026-04-03
Not yet recruiting
- Phase 2 Platform Trial of Long-acting Antibodies for Moderately to Severely Active Ulcerative Colitis
- Ulcerative Colitis
- Nguyen Deanna
- 2026-04-01
Recruiting
- Tracing O-17 water between eyes and brains
- Dementia, Eye diseases, Brain diseases
- Miyata Mari
- 2026-03-30
Not yet recruiting
- Maintenance Effects of the Maudsley Model for Anorexia Nervosa: A Randomized Controlled Trial Investigating Neural Mechanisms
- Anorexia Nervosa
- Nakazato Michiko
- 2026-03-25
Recruiting
- Pre-Operative Synbiotics Treatment for Children With Medical Complexity
- Children with medical complexity who are scheduled to undergo gastrostomy, fundoplication, or trache
- Kawaguchi Yunosuke
- 2026-03-25
Not yet recruiting
- A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Takizawa Manami
- 2026-02-13
Recruiting
- JCOG2402: A randomized phase III study of response-guided therapy in premenopausal patients with early breast cancer
- ER-positive, HER2-negative invasive breast cancer
- KANEMITSU Yukihide
- 2026-01-27